Clinical Trial

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Recruiting
View on ClinicalTrials.gov →
Summary
This study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) restores the appropriate UVB response. Ongoing studies have tested the ability of fractionated laser resurfacing (FLR) to assess how long this wounding effect lasts-and have found that this appears to be a durable response which lasts for at least two years. The findings that FLR protects geriatric skin at two years is the impetus for this study. This study is an interventional study to assess if FLR treatment of one forearm of geriatric subjects with multiple actinic keratosis will result in the short-term removal of actinic keratosis, and the long-term decrease in levels of future actinic keratosis and other non-melanoma skin cancers in comparison to the untreated arm. Study length and visit: The first part of the study is completed in 1 day then there are follow up visits at 90 days and every 6 months for 5 years.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-04-05; most recent amendment 2026-07-15.
Status change: Enrolling by Invitation → Recruiting 2022-08-17
Status change: Recruiting → Enrolling by Invitation 2021-04-06
Trial Details
NCT Number NCT03906253
Lead Sponsor Wright State University
Conditions Actinic Keratoses, Aging, Non-Melanoma Skin Cancer
Enrollment 72 participants
Start Date 2018-01-10
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-17